When available, the Online Course format is included with the hard copy, eBook, or audio book formats!
Release Date: July 30, 2013
Review Date: May 18, 2016
Expiration Date: May 17, 2019
Methicillin-resistant Staphylococcus aureus (MRSA) was identified in scientific literature in the early 1960s as the major cause of healthcare associated infections. It was first referred to as hospital-acquired methicillin-resistant Staphylococcus aureus (HA-MRSA), a strain detected in older patients with underlying medical conditions who developed infections as the direct result of their exposure to a healthcare setting. Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) was identified in 1981 as a new pathogen, emerging in young, healthy, and nonhospitalized individuals within the community. MRSA is a form of staphylococcal infections that involves bacteria that have developed a resistance, over time, to most common antibiotics used for soft tissue and skin infections. The focus of current research is active surveillance in the healthcare setting, followed by contact precautions as indicated, development of newer and more potent antibiotics and antibacterial vaccines, improved infection control techniques, and safer surgical procedures. The White House’s national strategy regarding MRSA is to reduce the incidence of infection by at least 50% overall by 2020 as compared to 2011.
This basic-level course describes the difference between the hospital and community strains of MRSA. The epidemiology, risk groups, and modes of transmission of MRSA are outlined along with the currently available treatment modalities. This course will help clinicians incorporate the CDC Guidelines into their clinical practice to reduce cross-transmission of potential pathogens.
AGD Subject Code: 148
Western Schools designates this activity for 2 continuing education credits.
- Describe the epidemiology of methicillin-resistant Staphylococcus aureus (MRSA), including its etiology, prevalence, and incidence.
- Differentiate between the hospital- and community-acquired strains of MRSA, including risk factors.
- Outline the infection-control protocols used to prevent transmission of MRSA in hospital and community settings.
- Identify infection control guidelines to prevent transmission of MRSA in dental settings.
Christine Wisnom, RN, BSN, is a nurse educator for the AIDS Education and Training Center in the Department of Oncology and Diagnostic Sciences at the University of Maryland School of Dentistry. She is a graduate of the University of Maryland School of Nursing. Her primary areas of interest are infectious diseases and infection control, and she lectures locally, nationally, and internationally on these topics. For many years, Ms. Wisnom served as both a member, and as the chair, of the Infection Control/Biosafety Committee at the University of Maryland School of Dentistry. She has published numerous articles and abstracts in both medical and dental journals.
- Courses must be completed within one (1) year of the date of purchase or by the expiration date indicated above, whichever date comes first.
- You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
- Through our review processes, Western Schools ensures that the course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools’ policy not to accept commercial support.
- All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.
- There are no prerequisites for this course.